This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Zhejiang Wanbang Pharmaceutical Plc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Weihua Xie: Innovator in Pharmaceutical Chemistry
Introduction
Weihua Xie is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of important compounds used in the industry. His work is characterized by a focus on efficiency and purity, which are critical in pharmaceutical applications.
Latest Patents
One of Weihua Xie's key patents is titled "Preparation of (−)-huperzine A." This invention relates to a method for preparing (−)-huperzine A, which involves allowing a mixture of (±)-huperzine A obtained from chemical synthesis and a chiral acid to form (±)-huperzine A chiral acid salt under suitable conditions. The process includes recrystallizing the chiral acid salt from an organic solvent and basifying with an alkali to obtain optically pure (−)-huperzine A. The method is convenient to operate and suitable for industrial production. The chemical purity and optical purity of (−)-huperzine A obtained by this method are each greater than 99.5%, satisfying the requirement for raw pharmaceutical purity in the pharmaceutical industry.
Career Highlights
Weihua Xie is associated with Zhejiang Wanbang Pharmaceutical Plc., where he applies his expertise in pharmaceutical chemistry. His innovative approach has led to advancements in the production of high-purity compounds, which are essential for the development of effective medications.
Collaborations
Weihua has collaborated with notable colleagues such as Shaoping Peng and Ping Chen. Their combined efforts contribute to the ongoing research and development in the pharmaceutical sector.
Conclusion
Weihua Xie's contributions to pharmaceutical chemistry, particularly through his patent on (−)-huperzine A, highlight his role as an innovator in the field. His work not only enhances the efficiency of pharmaceutical production but also ensures the high purity of essential compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile